Clinical Trial Update: Sequential Intravesical Bacillus Calmette-Guérin and Electromotive Mitomycin-C After Transuretheral Resection [NA]

View source ↗

Summary

A clinical trial investigating sequential intravesical BCG and electromotive mitomycin-C after transurethral resection for bladder carcinoma was terminated; res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• Bacillus Calmette-Guérin (BCG) (Bacillus Calmette-Guérin)
• mitomycin-C (electromotive administration) (mitomycin-C)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Bladder Carcinoma | NA | Status: TERMINATED | Results posted: 2019-06-14